The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
The 21-gene recurrence score (RS) assay helps guide adjuvant chemotherapy use for patients with breast cancer, and is predicted to reduce overall chemotherapy use. Little is known about recent patterns of testing in the Medicare program and the impact of testing on chemotherapy use as a function of patient age.We conducted a national claims—based study of Medicare beneficiaries age ≥66years. We assessed...
The global incidence of cancer is expected to increase dramatically in the coming years, due in part to ageing populations. Historically, elderly women with breast cancer have been excluded from clinical trials, making it difficult to develop evidence-based treatment guidelines. Ageing is a highly individualised process and age alone should not be used to deny treatment to otherwise appropriate patients...
Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.